Email Sign-Up
 
1887 results found
Filter Filters icon
Apply

Bio

Abby Match

Article

Accessibility policy

Bio

Neeta Mehta MBA

Bio

Amy R. Gavin

Bio

Caroline Abi-Khattar Esq.

Article

Ribociclib

Ribociclib (Kisqali), a targeted therapy, is the second CDK 4/6 inhibitor to be approved by the FDA. It targets two specific kinases, or enzymes, that help tumor cells grow and divide.

Article

Palbociclib

Palbociclib (Ibrance), a targeted therapy, was the first CDK 4/6 inhibitor to be approved by the FDA. It targets two specific kinases, or enzymes, that help tumor cells grow and divide.

Article

Abemaciclib

Abemaciclib (Verzenio) is a targeted therapy approved by the Food and Drug Administration to treat hormone receptor-positive breast cancer.

Article

Targeted therapy for hormone-receptor positive breast cancer

Targeted therapies are treatments that target specific proteins or markers on or within cancer cells that help cancer cells grow. There are many different kinds of targeted therapy. Hormonal ...

Story 12/22/22

Babytam effective in preventing breast cancer

Low-dose tamoxifen, or “Babytam,” can prevent breast cancer recurrence among people with high-risk lesions, such as those with DCIS, LCIS, or atypical ductal hyperplasia
[class^="wpforms-"]
[class^="wpforms-"]
[item.name]
[item.name]
[item]
[item]